Sotrovimab for COVID-19
41st treatment shown to reduce risk in
May 2023
Lower risk for ICU admission and hospitalization.
No treatment is 100% effective. Protocols
combine treatments. * >10%
efficacy, ≥3 studies.
4,800+ studies for
95 treatments. c19early.org
|